Internal Medicine · Honolulu, HI
NPI
1962578476
Since 2006
Specialty
Internal Medicine
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1824 Dillingham Blvd
Honolulu, HI, 96819
Phone (808) 848-1515
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
238 services
Medicare patients, 2024
58
Average age 72
Drug cost, 2024
$2.6M
10,323 prescriptions
Company payments, 2025
$5,781
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anthony C Hernandez was code 99214 (office e&m - established), 108 times for 50 patients. In total Anthony C Hernandez billed 238 services in 6 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-10-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 108 | 50 | $79.85 | $8,624 |
| 99213 Office E&M - Established | Office | 97 | 39 | $50.15 | $4,865 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 26 | 26 | $128.54 | $3,342 |
By year: 2022 $14K for 202 services; 2023 $15K for 227 services; 2024 $17K for 238 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anthony C Hernandez prescribed most often to Medicare patients was Losartan Potassium, with 744 prescriptions and refills. In total Anthony C Hernandez wrote 10,323 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 744 | 2,185 | 210 | $9,704 |
| Amlodipine Besylate Generic | 676 | 1,893 | 188 | $6,265 |
| Atorvastatin Calcium Generic | 549 | 1,601 | 162 | $9,012 |
| Rosuvastatin Calcium Generic | 536 | 1,564 | 163 | $13K |
| Farxiga Dapagliflozin Propanediol | 495 | 1,056 | 120 | $600K |
| Metformin Hcl Generic | 392 | 1,085 | 114 | $2,713 |
| Celecoxib Generic | 330 | 422 | 121 | $6,256 |
| Olmesartan Medoxomil Generic | 245 | 708 | 70 | $9,217 |
| Azithromycin Generic | 208 | 208 | 155 | $1,358 |
| Jardiance Empagliflozin | 189 | 412 | 48 | $246K |
| Vascepa Icosapent Ethyl | 182 | 408 | 41 | $131K |
| Levothyroxine Sodium Generic | 173 | 522 | 52 | $1,055 |
| Livalo Pitavastatin Calcium | 172 | 410 | 42 | $134K |
| Metoprolol Succinate Generic | 170 | 473 | 50 | $2,592 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 163 | 475 | 46 | $3,216 |
Brand drugs: 2,210 claims; generic drugs: 8,050 claims; opioid claims: 71.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anthony C Hernandez $5,781 ($5,781 in general payments such as food, travel and fees) from 14 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,800.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 46 | $1,800 |
| Novo Nordisk Inc NVO | 26 | $779 |
| Amgen Inc. AMGN | 14 | $710 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 13 | $479 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $446 |
| Kowa Pharmaceuticals America, Inc. | 17 | $429 |
| Gilead Sciences, Inc. GILD | 8 | $282 |
| GlaxoSmithKline, LLC. GSK | 10 | $278 |
| Esperion Therapeutics, Inc. ESPR | 11 | $170 |
| Lilly USA, LLC LLY | 3 | $167 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.